bearish
Nippon Suisan (1332)--Stalled EPA Sales to Amarin
2.3k Views04 Dec 2018 11:51
Nippon Suisan ("Nissui") has a new fish-oil EPA plant with 420 tons/year in capacity and is currently operating at 50% utilization. The company...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Amarin--Our Talks With The CEO & An Update on New Trial Data Released at ACC Conference25 Mar 2019
- Amarin Q4 2018 Conference Call--Strong Sales & High Confidence28 Feb 2019
- Amarin--2019's Biggest Buyout Target for Big Pharma07 Jan 2019
- Nippon Suisan--Amarin Reports 25% Risk Reduction in Clinical Trial, Better than Lipitor Results25 Sep 2018
- Nippon Suisan (1332)--Update on Amarin's Reduce-It Trial Data Scheduled for Release by Month-End14 Sep 2018
x